Cancer on $5 a Day (Chemo Not Included)

If you enjoy a good laugh, and are not easily offended, then this is a book you simply must read. In Cancer on $5 a Day (Chemo Not Included), Robert Schimmel describes his true-life adventures battling cancer. Schimmel was a comedian whose fortunes were in the fast lane – HBO specials, bestselling CDs, and sold-out club appearances – when, in 2000, he learned to his horror that he had Stage III Hodgkin's Lymphoma, hardly a fit subject for a stand-up monologue. Unless you choose to make it so funny it doesn't hurt so much, which is what Schimmel has done.
He tries to keep the dread news light by indulging in some grim repartee with his docs and putting a smile on the faces of the fellow patients he encounters.

It isn't always easy. At one group session he hears from some other cancer sufferers:

"One guy, testicular, tells us that he was diagnosed five years ago and now he's skiing and snowboarding and skydiving. I choke up when he speaks. I vow that that's going to be me. Minus the skiing and snowboarding and skydiving."

His description of having one of his testicles removed and replaced with a prosthetic sphere is laugh out loud funny, but for mature audiences only. The twice-divorced dad who lost his 11 year old son to cancer, manages to be heroic without the sappy sentimentality we’re used to in such survivor stories.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap